J. Donald Easton

TL;DR: Apixaban appears to be cost-effective relative to warfarin for secondary stroke prevention in patients with AF, assuming that it is introduced at a price similar to that of dabigatran.

TL;DR: Lotrafiban at doses of up to 50 mg twice daily was well-tolerated in a 12-week, double-blind, placebo-controlled, dose-ranging study in patients with recent myocardial infarction, unstable angina, transient ischemic attack, or stroke when added to aspirin therapy.

TL;DR: Six patients with acute anxiety-like attacks are described who, it is believed, are suffering from "beta-Adrenergic hyperactivity", and treatment with propranolol hydrochloride produced longterm symptomatic relief.

TL;DR: The data are consistent with, but do not prove the hypothesis that early addition of clopidogrel to acetylsalicylic acid in patients with transient ischaemic attack and ischaemia stroke of arterial origin may be more effective and acceptably safe compared with acetyl salicylic Acid alone.

TL;DR: HIS call-to-action document is an initiative of the Prevention of Atherothrombotic Disease Network, an international, multidisciplinary network, adjoined by the mutual goal of increasing awareness, detection, and treatment rates of peripheral arterial disease (PAD) and increasing awareness of the interrelationship between PAD and the risk of ischemic events.